GHK-Cu: What the science really says about the "copper peptide"
GHK-Cu is a tiny copper-carrying peptide your body makes naturally, and it's been a skin-care ingredient for years. Now people are injecting it, alone or in blends like GLOW and KLOW, hoping for better skin, hair and healing. Here's what the research shows for creams compared with injections, what's known about safety, and where GHK-Cu stands with the FDA.
What is GHK-Cu?
GHK-Cu is made of three amino acids: glycine (G), histidine (H) and lysine (K), holding onto a copper ion. It was discovered in 1973, when researcher Loren Pickart found that something in the blood of young people made older liver tissue behave more like young tissue. That something was GHK.1
Levels of GHK in the blood drop as we age, from about 200 nanograms per milliliter at age 20 to about 80 by age 60. That decline is part of why GHK-Cu attracts interest as an "anti-aging" molecule, though no study has shown that topping it up slows aging in people.1
Why researchers are excited
In the lab, GHK-Cu does a lot:1
- Builds skin structure. It boosts production of collagen and elastin, the proteins that keep skin firm and springy.1,3
- Supports repair. It promotes new blood vessel and nerve growth, and it improved wound healing in rabbits, rats, mice and pigs.1
- Changes gene activity. In lab studies, GHK changed the activity of a large share of human genes, including many linked to tissue repair.1
Much of this research comes from scientists connected to companies that make GHK-based products, so independent confirmation matters.1
What about people?
Here's the key distinction: GHK-Cu applied to the skin has been tested in people. Injected GHK-Cu has not.4
| Study | Who | What happened | Big caveat |
|---|---|---|---|
| Collagen Abdulghani et al., 1998 | 20 volunteers, cream on thigh skin for 1 month | Collagen production rose in 70% of people with GHK-Cu, vs. 50% with vitamin C and 40% with retinoic acid2 | Small; skin samples, not appearance |
| Face and eye creams Leyden et al., 2002 | 71 women (face) and 41 women (eyes), 12 weeks | Thicker, denser skin and fewer fine lines and wrinkles2 | Conference abstracts only, not full papers |
| Wrinkles Badenhorst et al., 2016 | 40 women ages 40–65, 8 weeks | Wrinkle volume fell 55.8% more than with a plain serum, and 31.6% more than with another peptide cream3 | Small, short trial of a special formulation |
| After laser skin treatment | 13 patients | No significant differences on objective measures5 | Very small |
| Injections | None | No published human studies4 | Safety and benefit unknown |
A 2025 review called the number of clinical studies on these skin peptides surprisingly small, and noted that no studies had been published on their possible side effects.2 Dermatologists describe the skin-care science as solid but limited. As one put it, they'd advise against injecting until human studies are done.4
Is GHK-Cu safe?
It depends a lot on how it's used.
- On the skin: Copper peptide creams have been sold for years with few reported problems, though formal safety studies are lacking.1,2
- By injection: No safety studies exist. One clinician who treats people who self-inject reports injection-site irritation and infections, and in more serious cases raised liver enzymes and high copper levels, often in people who weren't getting lab monitoring. It's not clear whether the peptide or impurities caused these problems.4
- Copper overload and immune reactions are the main theoretical risks of injecting.4 People with conditions that affect how the body handles copper, such as Wilson's disease, should be especially cautious.
- Product quality. Injectable GHK-Cu is mostly sold online as a "research" product, and experts worry some products may not contain what the label says.4
Athletes: Copper peptide skin-care products are generally not a concern for anti-doping. Injectable GHK-Cu isn't specifically named on the World Anti-Doping Agency's list, but unapproved injectables can raise issues, so check with your anti-doping authority.9
Where GHK-Cu stands with the FDA
GHK-Cu is not an FDA-approved drug, but copper peptides can be sold as cosmetic skin-care ingredients. For compounding pharmacies, the FDA treats routes differently: non-injectable GHK-Cu has been in "Category 1," which pharmacies can generally use, while the injectable form was on the restricted "Category 2" list until April 2026.5,7
Coming off Category 2 didn't make injectable GHK-Cu eligible for compounding. It's one of five peptides an FDA advisory committee is expected to review at a second meeting before the end of February 2027.6
How GHK-Cu's status has changed
- 1973GHK discovered in human blood1
- 1990s–2010sSmall human studies of copper peptide skin creams2,3
- Before 2026Injectable GHK-Cu on the FDA's restricted Category 2 list; non-injectable forms in Category 15
- April 2026Injectable GHK-Cu removed from Category 2, with 11 other peptides7
- September 2026FDA warns online sellers of unapproved "research" peptides; NPR reports injections are outpacing the science4,8
- October 14–15, 2026HHS sends an "interim access policy" for certain peptides to the White House. Which peptides it covers hasn't been made public6,10
- By February 2027FDA advisory committee expected to review injectable GHK-Cu6
What this means for you: Copper peptide skin care is legal and widely available. Injectable GHK-Cu is still in regulatory limbo, and we'll update this article after the FDA's advisers review it.
If you're curious about GHK-Cu
- Start with skin care. Copper peptide serums and creams are the best-studied way to use it.
- Build on proven basics. Daily sunscreen and retinoids have the strongest evidence for aging skin.
- Thinning hair or slow-healing wounds? See a dermatologist or doctor. Proven treatments exist.
- Skip "research use only" injectables. Contents and sterility can't be verified.
- Tell your doctor about any peptides you use, especially if you have liver disease or a copper-related condition.
The bottom line
GHK-Cu has one of the longest research histories of any peptide in our series. It's a natural molecule that declines with age, and small skin-cream studies suggest it can help skin look firmer and less wrinkled. That's genuinely encouraging. But the leap from cream to injection has gotten far ahead of the science: there are no human studies of injected GHK-Cu, and clinicians are already seeing problems in people who self-inject. For now, GHK-Cu belongs on your skin, not in a syringe.
References
- Pickart L, Margolina A. Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data. Int J Mol Sci. 2018;19(7):1987. mdpi.com
- Mortazavi SM, Mohammadi Vadoud SA, Moghimi HR. Topically applied GHK as an anti-wrinkle peptide: advantages, problems and prospective. BioImpacts. 2025;15(1):30071. tbzmed.ac.ir
- Badenhorst T, Svirskis D, Merrilees M, Bolke L, Wu Z. Effects of GHK-Cu on MMP and TIMP expression, collagen and elastin production, and facial wrinkle parameters. J Aging Sci. 2016;4(3):1–7. walshmedicalmedia.com
- Stone W. The copper peptide trend has gone from creams to injections, ahead of the science. NPR; September 7, 2026. wunc.org
- Superpower. GLOW peptide blend: GHK-Cu, BPC-157 and TB-500, and how KLOW differs; updated September 28, 2026. superpower.com
- Holland & Knight. Peptides at a crossroads: what wellness providers need to know; October 16, 2026. hklaw.com
- 503Pharma. FDA pulls 12 peptides from Category 2 list; April 2026. beehiiv.com
- Pharmaceutical Technology. FDA cracks down on black market peptide trade; September 2, 2026. pharmaceutical-technology.com
- Peptide Journal. Peptides and WADA: anti-doping rules for athletes; November 2025. peptidejournal.org
- Associated Press. Trump administration advances plan for peptide drugs favored by RFK Jr. ABC News; October 15, 2026. abcnews.com
This article is for general education and is not medical advice. GHK-Cu is not approved by the FDA to diagnose, treat, cure or prevent any condition, and this article does not recommend injecting it or provide dosing information. Talk with a licensed healthcare provider before starting any new treatment. Regulatory information is current as of October 22, 2026 and is changing quickly. Charts and illustrations are original works by Peptide Advocate.
